What if the sequence is incomplete?

Do not submit the order. An incomplete or ambiguous sequence can produce the wrong peptide; require a complete, validated sequence and any modification annotations before routing to synthesis.

Can I collect signatures electronically?

Yes. Electronic signatures are valid under the ESIGN Act (15 U.S.C. ch. 96, 2000) and UETA where adopted, provided intent, consent, attribution, and record retention are satisfied.

Is HIPAA relevant to this form?

Only if the form contains protected health information. If PHI is present, execute a Business Associate Agreement with vendors and apply HIPAA safeguards (45 CFR §164.530(j)).

Do I need a notary or witnesses?

Most peptide orders do not require notarization; use a notary only when required by contract or if the form will serve as legal evidence in custody or transfer disputes.

How do I correct an error after signing?

Create an amendment or new form with a clear revision history and new signatures. Do not alter the original signed record; preserve it for audit.

How long must I retain signed forms?

Retention depends on use: follow IRS minima (3 years, IRC §6501(a)), HIPAA (6 years, 45 CFR §164.530(j)) and any contract or state-specific longer periods.

Electronic Signature
Templates
Miscellaneous
Miscellaneous Peptide Form

Miscellaneous Peptide Form

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

MISCELLANEOUS PEPTIDE FORM

This Miscellaneous Peptide Form (the Agreement) is entered into as of Effective Date: by and between Client Name: (Client) and Supplier Name: (Supplier).

RECITALS

WHEREAS, Supplier synthesizes, purifies and supplies synthetic peptides and related materials for laboratory, research and development use; and

WHEREAS, Client desires to purchase certain peptide products and related services from Supplier under the terms set forth in this Agreement; and

WHEREAS, the parties intend to memorialize the scope of work, payment, confidentiality and other commercial terms applicable to the supply, handling and acceptance of the peptides described below.

SCOPE OF WORK

Supplier will provide peptides and related services in accordance with the specifications and quantities set forth below. Supplier shall perform synthesis, purification and quality control described herein, and deliver peptides to Client in appropriate packaging consistent with biohazard and cold-chain requirements where applicable.

Peptide Specifications (list each item separately): Peptide Item - Sequence / Catalog No.

Quantity

Purity

Storage Condition

PAYMENT TERMS

Client shall pay Supplier for peptides and services as follows. The stated fees do not include taxes, duties or courier charges unless expressly specified.

Total Purchase Price Payment Schedule Deposit Amount (if applicable) Late Payment Fee

TERM AND TERMINATION

This Agreement commences on Start Date: and continues until End Date: unless earlier terminated in accordance with this section.

Either party may terminate this Agreement for material breach by the other party upon written notice and a cure period of Notice Period: if the breach remains uncured at the expiration of the cure period. Termination shall not relieve Client of its obligation to pay for products and services delivered prior to the effective date of termination.

CONFIDENTIALITY

Each party shall keep confidential all technical, business and pricing information disclosed by the other party that is marked confidential or that, by its nature, should reasonably be considered confidential. Confidential information shall not be disclosed except to employees, agents or contractors who have a need to know and who are bound by confidentiality obligations no less protective than those herein. Confidentiality obligations survive termination for a period of five (5) years.

Intended Use (select all that apply)

For Research Use Only (RUO) Drug Discovery / Preclinical Research Intended for Human Clinical Use

Client acknowledges and agrees that unless expressly stated in writing by Supplier, peptides supplied hereunder are not approved for human clinical use. If Client selects Intended for Human Clinical Use, Client shall provide all necessary regulatory approvals and shall indemnify Supplier for any use outside of permitted research uses.

SHIPPING, STORAGE AND CHAIN OF CUSTODY

Supplier will ship products under the Shipping Conditions specified below. Client is responsible for storage at arrival and compliance with handling instructions. Supplier will document chain of custody and provide certificates of analysis where applicable.

Shipping Conditions Chain of Custody / Handling Instructions

WARRANTIES AND DISCLAIMERS

Supplier warrants that peptides supplied shall conform to the specifications expressly set forth in this Agreement and any applicable certificate of analysis at time of shipment. EXCEPT FOR THE FOREGOING WARRANTY, SUPPLIER MAKES NO OTHER WARRANTIES, EXPRESS OR IMPLIED, INCLUDING IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. CLIENT SHALL INSPECT PRODUCTS PROMPTLY UPON RECEIPT AND NOTIFY SUPPLIER IN WRITING OF ANY NONCONFORMITY WITHIN Ten (10) DAYS OF RECEIPT. Failure to provide such notice shall constitute acceptance.

LIMITATION OF LIABILITY

IN NO EVENT SHALL EITHER PARTY BE LIABLE FOR INDIRECT, INCIDENTAL, SPECIAL OR CONSEQUENTIAL DAMAGES. SUPPLIER'S AGGREGATE LIABILITY FOR BREACH ARISING OUT OF OR RELATED TO THIS AGREEMENT SHALL NOT EXCEED THE AMOUNTS PAID BY CLIENT TO SUPPLIER UNDER THIS AGREEMENT WITH RESPECT TO THE SPECIFIC ORDER GIVING RISE TO LIABILITY.

GOVERNING LAW

This Agreement shall be governed by and construed in accordance with the laws of the State of without regard to its conflict of laws principles. Exclusive venue for any dispute shall be in the state or federal courts located in that state.

ENTIRE AGREEMENT

This Agreement, including any purchase orders and attachments expressly incorporated by reference, constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior and contemporaneous agreements, understandings, negotiations and communications, both written and oral. Any modifications must be in writing and signed by authorized representatives of both parties.

ADDITIONAL INFORMATION

Client Billing Address Supplier Address Primary Contact - Client Primary Contact - Supplier

Client:

By:

Date:

Supplier:

By:

Date:

What the Miscellaneous Peptide Form Is and when it's used

The Miscellaneous Peptide Form is a standardized document used to record requests, chain-of-custody, specifications, and approvals for peptide materials in research, clinical, and manufacturing workflows. Typical uses include ordering custom-synthesized peptides, documenting storage and handling instructions (concentration, solvent, temperature), recording lot and purity details, and capturing recipient acknowledgements for transfer or disposal. The form helps create a verifiable record that supports quality control, regulatory review, and procurement tracking while centralizing contact, billing, and project identifiers.

Why this form matters for accuracy and compliance

A clear Miscellaneous Peptide Form reduces errors in synthesis instructions, ensures proper chain-of-custody, and documents approvals that may be required for controlled experiments or regulated transfers. Proper completion supports laboratory traceability, billing accuracy, and retention requirements under healthcare and tax rules.

Who typically completes and signs this form

Organizations and roles that commonly use this form include laboratory managers, procurement staff, research investigators, and quality assurance personnel.

Use signatures from authorized personnel only; the signatory should match the role identified in internal approval matrices.

Step-by-step: complete and route the Miscellaneous Peptide Form

Follow this sequence to prepare, approve, and record a peptide request to minimize delays and ensure traceability.

01

Prepare form: Enter requester, sequence, specs, and safety notes.
02

Attach support docs: Include protocol excerpts, SDS, and regulatory approvals.
03

Obtain approvals: Route to lab manager, safety officer, and fiscal approver.
04

Record disposition: Log receipt, QC results, and final storage location.

Essential data elements and privacy considerations

Personal Data: Limit to necessary fields only

PHI Handling: Use only when HIPAA applies

Audit Trail: Record time-stamped actions

Access Controls: Restrict by role

Encryption: Encrypt records at rest and transit

Retention Tag: Mark per retention policy

Where to send the completed form and supporting files

Routing depends on whether the peptide is for internal research, clinical use, or manufacture; include electronic and physical destinations.

Research Procurement: Send to purchasing department or procurement portal
Vendor Submission: Attach form when placing order with synthesis vendor
Laboratory Receipt: Deliver to receiving lab plus QC team
Storage Records: File with inventory management system

How to set up a digital workflow for this form

Use these common settings when configuring an electronic form and approval flow to support traceability and security.

Field	Configuration
Signature Type	Electronic signature with audit trail
Authentication	Email link or SMS code
Attachments	Allow PDF, DOCX, SDS uploads
Retention Flag	Auto-tag by project and retention period

Digital signing, storage, and integration considerations

Verify that the eSignature platform supports your required security, audit, and integration features before e-submitting forms.

Integrations: Connect to systems like Google Workspace, Microsoft 365, Salesforce
Document formats: Accepts PDF and DOCX with embedded audit trail
Compliance: Supports HIPAA BAA, ESIGN, UETA, 21 CFR Part 11

Maintain copies in your document management system and confirm that retention tags and access controls are applied to signed records.

Timelines and processing expectations

Know standard timeframes so projects and procurement milestones stay on schedule.

Order lead time:

Custom peptides typically require 1–4 weeks depending on complexity

QC turnaround:

Purity and identity testing commonly add 2–7 days

Billing cycle:

Vendor invoicing varies; expect net 30 terms

Retention trigger:

Retention begins on signature or material receipt, per policy

Urgent orders:

Expedited synthesis may reduce lead time at additional cost

Common preparation mistakes to avoid

Missing or ambiguous peptide sequence details that cause synthesis errors or delays.
Omitting storage or solvent instructions that lead to degradation in transit.
Using incorrect units (mg vs µmol) for quantity requests.
Not attaching required safety data (SDS) when hazardous solvents or modifications are involved.

Risks and compliance consequences of incorrect forms

Research Delay: Missed experiment timelines and project overruns

Financial Penalty: Vendor disputes or rework costs

Data Integrity: Irrecoverable sample contamination or misidentification

HIPAA Exposure: Potential reportable breach if PHI mishandled

Regulatory Risk: Noncompliance with FDA record rules where applicable

Audit Failure: Missing traceability in inspections

Typical eSignature vendor comparison for signing and routing this form

Compare common vendor attributes relevant to secure signing and regulatory compliance; signNow is listed first for direct feature comparison.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day trial	Varies by plan	Varies by plan	Varies by plan	Varies by plan
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No

Real-world examples of form use

Examples below show how organizations document peptide orders and approvals in practice.

Optica Ventures — lab order

A small research lab standardized the request form to include sequence and solvent

This cut clarification emails by half
The lab saw fewer synthesis errors and a clearer audit trail for experiments and invoices.

Fertility Centers — clinical chain-of-custody

A clinical center used a signed form for peptide reagents used in diagnostics

Signatures were captured electronically with an audit trail
The record supported HIPAA-compliant handling and simplified regulatory readiness.

Practical tips for accurate and efficient completion

Adopt consistent templates and validation checks to reduce manual errors and speed approvals.

Use standardized templates

Pre-fill institutional fields and validation rules to reduce free-text errors and speed procurement.

Require essential attachments

Mandate SDS and protocol excerpts for hazardous or modified peptides to avoid shipping delays.

Apply role-based approvals

Configure signer order so technical, safety, and fiscal approvals occur in the correct sequence.

Preserve audit trails

Ensure signed PDFs include a tamper-evident certificate and metadata for inspections or audits.

FAQs and troubleshooting for common issues

Answers to frequent questions about completion, signing, and retention of the Miscellaneous Peptide Form.

Need help? Contact support

What if the sequence is incomplete?
Do not submit the order. An incomplete or ambiguous sequence can produce the wrong peptide; require a complete, validated sequence and any modification annotations before routing to synthesis.
Can I collect signatures electronically?
Yes. Electronic signatures are valid under the ESIGN Act (15 U.S.C. ch. 96, 2000) and UETA where adopted, provided intent, consent, attribution, and record retention are satisfied.
Is HIPAA relevant to this form?
Only if the form contains protected health information. If PHI is present, execute a Business Associate Agreement with vendors and apply HIPAA safeguards (45 CFR §164.530(j)).
Do I need a notary or witnesses?
Most peptide orders do not require notarization; use a notary only when required by contract or if the form will serve as legal evidence in custody or transfer disputes.
How do I correct an error after signing?
Create an amendment or new form with a clear revision history and new signatures. Do not alter the original signed record; preserve it for audit.
How long must I retain signed forms?
Retention depends on use: follow IRS minima (3 years, IRC §6501(a)), HIPAA (6 years, 45 CFR §164.530(j)) and any contract or state-specific longer periods.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now